166 filings
Page 6 of 9
6-K
4dz ou5iq1bs
3 Jan 18
Current report (foreign)
12:00am
6-K
q3tqu84etee 4hhysx
2 Jan 18
Current report (foreign)
12:00am
6-K
aeohum1n7bre
22 Dec 17
Current report (foreign)
12:00am
6-K
6w5ke4t bc
9 Nov 17
Galmed Pharmaceuticals Reports Third Quarter 2017 Financial Results and Provides Business Update
12:00am
6-K
pst 5ds99
5 Oct 17
Galmed Pharmaceuticals Announces Publication of Data on AramcholTM
12:00am
6-K
jwvspz0umyol
7 Aug 17
Current report (foreign)
12:00am
6-K
nbys1jl 14sl33gye3
4 Aug 17
Galmed Pharmaceuticals Announces Pricing of Offering of Ordinary Shares to Existing Investors and Members of the Board of Directors
12:00am
6-K
e9si3yn
31 Jul 17
Galmed Pharmaceuticals Reports Second Quarter 2017 Financial Results and Provides Business Update
12:00am
6-K/A
qslv 12p5rcdk
23 Jun 17
Current report (foreign) (amended)
12:00am
6-K
aa81uou q39f5c220
8 Jun 17
Galmed Pharmaceuticals Announces the Election of Dr. Carol L. Brosgart as a New Member of the Board of Directors
12:00am
6-K
i3ww7
8 Jun 17
Current report (foreign)
12:00am
6-K
rlsgvmxj4 4s
15 May 17
Galmed Pharmaceuticals Reports First Quarter 2017 Financial Results
12:00am
6-K
5guekk3yw 5ds
27 Apr 17
Current report (foreign)
12:00am
6-K
u94l91clrx ym
5 Apr 17
Galmed Pharmaceuticals to Present at International Liver Congress Data that Shows AramcholTMhas a Potential Direct Effect on Liver Fibrosis
12:00am
6-K
9tx fuoexfz
23 Mar 17
Galmed Pharmaceuticals Reports Fourth Quarter and Full Year 2016 Financial Results
12:00am
6-K
jmzsi0 nfk
15 Mar 17
Current report (foreign)
12:00am
6-K
87yv1v3f4i
9 Jan 17
Galmed Pharmaceuticals Completes Patient Recruitment for ARREST Phase IIb NASH study
12:00am
6-K
z076s1y6wuifa1dnyo15
7 Nov 16
Galmed Pharmaceuticals Reports Third Quarter 2016 Financial Results and Provides Business Update
12:00am
6-K
b14z6ll4hq qm83
29 Sep 16
Galmed Pharmaceuticals Announces that it has Raised Approximately $5.0 Million to Date Under its ATM Program
12:00am
6-K
pnjibrg wz
22 Sep 16
Current report (foreign)
12:00am